As shown in Figure 2E-F, in the B16-CD133 model M8-tetramer+ CD8+ T cells per gram also increased in both primary and secondary tumor of hRT/lena-treated mice compared to control mice and the respective monotherapies. This evidence concerns the gene CD8A and neoplasm.